We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+0.8%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$176M
AUM Growth
+$6.73M
(+4%)
Cap. Flow
+$1.88M
Cap. Flow
% of AUM
1.07%
Top 10 Holdings %
Top 10 Hldgs %
60.97%
Holding
239
New
27
Increased
123
Reduced
77
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Syntax Stratified LargeCap ETF
SSPY
|
+$2.29M |
| 2 |
Bunge Global
BG
|
+$400K |
| 3 |
Tesla
TSLA
|
+$256K |
| 4 |
Steel Dynamics
STLD
|
+$246K |
| 5 |
Charter Communications
CHTR
|
+$239K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KYNB
Kyntra Bio
KYNB
|
+$6.65M |
| 2 |
Meta Platforms (Facebook)
META
|
+$241K |
| 3 |
SIVB
SVB Financial Group
SIVB
|
+$217K |
| 4 |
FRC
First Republic Bank
FRC
|
+$216K |
| 5 |
Cigna
CI
|
+$206K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.2% |
| 2 | Technology | 7.91% |
| 3 | Consumer Staples | 7.41% |
| 4 | Consumer Discretionary | 6.26% |
| 5 | Communication Services | 3.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Sabre
SABR
$731M
| $80.2K | 0.05% |
18,693
+4,068
| +28% | +$23.3K |
|
227
8x8 Inc
EGHT
$269M
| $57.2K | 0.03% |
13,726
-2,851
| -17% | -$14.3K |
|
228
Lumen
LUMN
$6.57B
| $51.8K | 0.03% |
19,535
-43,511
| -69% | -$176K |
|
|
CNSL
229
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $51.3K | 0.03% |
19,870
+1,149
| +6% | +$4.12K |
|
|
TDAY
230
USA Today Co
TDAY
$1.27B
| $20K | 0.01% |
10,680
-536
| -5% | -$1.26K |
|
231
Nektar Therapeutics
NKTR
$2.39B
| $18.3K | 0.01% |
1,738
+955
| +122% | +$28.9K |
|
232
American Airlines Group
AAL
$10.1B
| – | – |
-11,418
| Closed | -$145K |
|
|
233
Cigna
CI
$73.8B
| – | – |
-621
| Closed | -$206K |
|
234
Coty
COTY
$2.42B
| – | – |
-12,115
| Closed | -$104K |
|
235
Organogenesis Holdings
ORGO
$305M
| – | – |
-21,123
| Closed | -$56.8K |
|
236
Unisys
UIS
$209M
| – | – |
-13,066
| Closed | -$66.8K |
|
|
FRC
237
DELISTED
First Republic Bank
FRC
| – | – |
-1,773
| Closed | -$216K |
|
|
SIVB
238
DELISTED
SVB Financial Group
SIVB
| – | – |
-942
| Closed | -$217K |
|
|
SBNY
239
DELISTED
Signature Bank
SBNY
| – | – |
-1,740
| Closed | -$200K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q1 2023 Portfolio in Review
As of Q1 2023, Vantage Consulting Group held 239 positions worth $176M, up 4% from $169M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Vantage Consulting Group's Q1 2023 filing shows 27 new, 123 increased, 77 reduced and 8 closed positions. Its largest new stake was Bunge Global: 4,120 shares worth $394K. The largest sale was Kyntra Bio, an estimated $6.65M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Staples.
- Vantage Consulting Group's largest Q1 2023 buy was Bunge Global: 4,120 shares worth $394K.
- Vantage Consulting Group added most to Syntax Stratified LargeCap ETF in Q1 2023, an estimated $2.29M increase.
- Vantage Consulting Group's biggest Q1 2023 reduction was Kyntra Bio, cutting an estimated $6.65M.
- Vantage Consulting Group fully exited SVB Financial Group in Q1 2023, selling an estimated $217K.
- Vantage Consulting Group's ten largest holdings make up 61% of its $176M portfolio in Q1 2023.
- Vantage Consulting Group opened 27 new positions and closed 8 in Q1 2023.
- Vantage Consulting Group's portfolio value rose 4% quarter-over-quarter to $176M.
Based on Vantage Consulting Group's 13F filing for Q1 2023, filed 10 May 2023.